Impact of COVID-19 Pandemic on Hepatopancreatobiliary Surgical Services in Singapore

COVID-19 Clinical Trial

Official title:

Before and After- Impact of COVID-19 Pandemic on Hepatobiliary and Pancreatic Surgical Services in Singapore: Retrospective Quantitative Study 2019-2022

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05572866
• Other study ID #: ttshhpb
• Status: Completed
• Start date: January 1, 2019
• Est. completion date: June 30, 2022

Study information

• Verified date: October 2022
• Source: Tan Tock Seng Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

This paper is intended to report our observational study in evaluating the impact of the COVID-19 pandemic on Tan Tock Seng Hospital hepatopancreatobiliary unit's surgical workload from January to June across 2019 to 2022, corresponding to the pre-pandemic baseline to its peak and the gradual normalization of hospital services as Singapore entered the transition phase to COVID-19 resilience.

Description:

This paper is intended to report our observational study in evaluating the impact of the COVID-19 pandemic on Tan Tock Seng Hospital hepatopancreatobiliary unit's surgical workload from January to June across 2019 to 2022, corresponding to the pre-pandemic baseline to its peak and the gradual normalization of hospital services as Singapore entered the transition phase to COVID-19 resilience.

A comparative audit of the unit's surgical workload for the months of January-June across 2019 to 2022, which corresponded to pre-COVID-19, the height of the pandemic, and a gradual normalization of surgical services. Operations performed by the unit were collected from the surgeons' electronic case logs. These operations were sorted based on the Singapore Ministry of Health's table of surgical procedures, which assigns charge codes to different procedures. The retrospective data across the 4 years were compared and analysed.

No patient contact or identifiers were retrieved, stored or disseminated and thus exempt from ethics board review.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 1089
• Est. completion date: June 30, 2022
• Est. primary completion date: June 30, 2022
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years to 120 Years

Eligibility

Inclusion Criteria:

• all patients who underwent gallbladder, hernia, liver or pancreas resection surgeries during the periods of January to June of 2019/2020/2021/2022.

Exclusion Criteria:

• anyone who does not fall within the inclusion criteria

Related Conditions & MeSH terms

• COVID-19
• Surgery

Intervention

Other:
• COVID-19 pandemic
To retrospectively review the surgical volume across 2019-2022 to see the impact of the COVID-19 pandemic.

Locations

Country	Name	City	State
Singapore	Tan Tock Seng Hospital	Singapore

Sponsors (1)

Lead Sponsor	Collaborator
Tan Tock Seng Hospital

Country where clinical trial is conducted

Singapore, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Number of surgeries done under general anaesthesia by the hepatopancreatobiliary unit	Operations performed by the unit will be collected from the surgeons' electronic case logs. These operations will be sorted based on the Singapore Ministry of Health's table of surgical procedures, which assigns charge codes to different procedures. The retrospective data across the 4 years will be compared and analysed.	2019-2022